By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.

OK

New York DFS Approval Looks in Sight for Aetna/CVS

Communications are ongoing between CVS and the New York Department of Financial Services as the two seek to resolve outstanding issues that would enable DFS tofeatured

Proposed NxStage/Fresenius Settlement Agreement Advanced to Commissioners

A proposed settlement agreement resolving the FTC’s Bureau of Competition’s concerns with Fresenius’s acquisition of NxStage appears to have passed to the commissioner levelfeatured

Update on New York and Other State Regulatory Reviews of Aetna/CVS Merger

The New York Department of Financial Services has limited leverage and is likely to come to a negotiated settlement with the parties as it reviews the merger of Aetna and CVS, New York legislative sources told CTFN.featured

NYDFS Public Hearing on Aetna/CVS Addresses Concerns and Possible Conditions

Opening the October 18 public hearing before the New York Department of Financial Services on the Aetna/CVS merger, DFS Superintendent Maria Vullo noted that her agency has approval authority over only one Aetna subsidiary,featured

NYDFS Public Hearing on Aetna/CVS Merger Set for Thursday

As the New York Department of Financial Services prepares to hold a hearing October 18 regarding the Aetna/CVS merger, it is understood that the parties are seeking to reach afeatured

Linde/Praxair Vote at FTC Could Come Any Day

A decision from the U.S. Federal Trade Commission regarding the merger of Linde and Praxair is expected “very soon,” a person with knowledge of the matter told CTFN.featured

Aetna/CVS Decision Imminent

A decision from the Department of Justice regarding CVS Health’s $69 billion acquisition of Aetna is expected before noon onfeatured

Aetna/CVS: Connecticut Public Hearing and States Update

Updated with Maryland Approval – On the sidelines of the Connecticut Insurance Department Form A hearing regarding CVS Health’s $69 billion acquisition of Aetna, CVS general counsel Tom Moriarty told CTFN the parties are making good progress with the pending antitrust reviewfeatured

Peritoneal Divestiture Also Required in Fresenius Acquisition of NxStage

The review by the U.S. Federal Trade Commission of the acquisition of NxStage by Fresenius is on track and moving forward, according to a source familiar with the matter.featured

Linde/Praxair One Step Closer to Completing Merger

The Korea Fair Trade Commission on October 3 issued a preliminary approval with additional demands for the Linde/Praxair merger, another step forward for the $83 billion transaction.featured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.